Provenance du réseau au premier degré de Manfred Gröppel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Manfred Gröppel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| 4SC AG | Biotechnology | Chairman Founder Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Masters Business Admin | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Chairman | |
| Immunic Research GmbH | Chief Executive Officer Chief Executive Officer | ||
DSM NV
 DSM NV Chemicals: SpecialtyProcess Industries DSM BV engages in the provision of ingredients, expertise, and solutions for plant-based products. It operates through the following segments: Animal Nutrition and Health (ANH); Health, Nutrition, and Care (HNC); Food and Beverage (F and B); and Other. The ANH segment includes developing sustainable animal farming through essential products, performance solutions, and precision services serving the poultry, swine, ruminants, and aquaculture markets. The HNC segment provides health, nutrition, and care solutions for markets such as early life nutrition, dietary supplements, pharma, medical, and personal care. The F and B segment focuses on supporting healthy diets through nutritious, delicious, and sustainable solutions for several market segments including bakery, beverages and brewing, dairy, savory, plant-based alternative proteins, and pet food. The Other segment is involved in corporate activities. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. | Chemicals: Specialty | Public Communications Contact Public Communications Contact | |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
Indigo Diabetes NV
 Indigo Diabetes NV Medical SpecialtiesHealth Technology Indigo Diabetes NV develops a needle-free glucose sensor by exploiting groundbreaking photonics technology. Its product addresses the need for accurate, low-cost glucose monitoring systems with an optimal user experience. The company was founded by Danae Delbeke on November 17, 2016 and is headquartered in Ghent, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
| LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member | |
| Technical University of Berlin | College/University | Doctorate Degree | |
| Bluehaven Therapeutics AG | Chief Executive Officer | ||
Efficas Medical Foods & Nutrition LLC
 Efficas Medical Foods & Nutrition LLC BiotechnologyHealth Technology Efficas Medical Foods & Nutrition LLC develops science-based consumer products for the nutritional management of the immune system for both humans and pets. Its products are non-prescription medical food and helps to provide relief from asthma and associated allergies. The company was founded by Nancy Fogg-Johnson and Alex Merolli in 2003 and is headquartered in Fullerton, CA. | Biotechnology | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
| Technische Universität Braunschweig | College/University | Undergraduate Degree | |
| Scibase AB | Director/Board Member | ||
| Weltoffen-Germering Weltladen eG | Director/Board Member | ||
4SC Discovery GmbH
 4SC Discovery GmbH BiotechnologyHealth Technology 4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member | |
Curexsys GmbH
 Curexsys GmbH Miscellaneous Commercial ServicesCommercial Services Curexsys GmbH is a German company founded by molecular biologist Jens Gruber and biochemist Dr. Herbert Stadler. The company is based in Goettingen, Germany. The company aims to become a leading supplier for clinical grade exosomes in regenerative medicine and anti-aging therapies. Exosomes are extracellular, nanoscale vesicles that transfer information to neighboring cells and distant tissues. Curexsys is currently pursuing the development of several programs in three indications, focusing on the generation of clearly defined, characterized, and purified extracellular vesicles/exosomes from their proprietary iMSC lines derived from Evotec's iPSC platform. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
| Affimed AG | Director/Board Member | ||
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member | |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member | |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal | |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 24 |
| Etats-Unis | 8 |
| Suisse | 6 |
| Belgique | 5 |
| Royaume-Uni | 4 |
Sectorielle
| Health Technology | 26 |
| Finance | 10 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 108 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 29 |
| Chief Executive Officer | 24 |
| Director of Finance/CFO | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Jörg Neermann | 34 |
| Vincent Ossipow | 22 |
| Tamara Favorito | 17 |
| Barclay Phillips | 16 |
| Thomas Taapken | 16 |
| Russell Cox | 13 |
| Duane Nash | 13 |
| Daniel Vitt | 13 |
| Andreas Muehler | 10 |
| Sanjay S. Patel | 10 |
| Jan Van den Bossche | 10 |
| Jan van den Bossche | 9 |
| Robert A. Ashley | 9 |
| Glenn Whaley | 7 |
- Bourse
- Insiders
- Manfred Gröppel
- Connexions Sociétés
